Waters (WAT) – Research Analysts’ Weekly Ratings Updates

Waters (NYSE: WAT) recently received a number of ratings updates from brokerages and research firms:

• 10/26/2026 – Waters was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/18/2026 – Waters was downgraded by Wall Street Zen from “buy” to “hold”.
• 10/15/2026 – Waters had its price target raised by Deutsche Bank Aktiengesellschaft from $400.00 to $440.00.
• 10/14/2026 – Waters had its price target raised by JPMorgan Chase & Co. from $400.00 to $435.00.
• 10/13/2026 – Waters had its price target raised by TD Cowen from $475.00 to $515.00. They now have a “buy” rating on the stock.
• 10/10/2026 – Waters was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/8/2026 – Waters was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 10/8/2026 – Waters had its price target raised by Robert W. Baird from $456.00 to $495.00. They now have an “outperform” rating on the stock.
• 10/7/2026 – Waters had its price target raised by Barclays from $460.00 to $500.00. They now have an “overweight” rating on the stock.
• 10/7/2026 – Waters had its price target raised by Evercore from $410.00 to $480.00.
• 10/1/2026 – Waters had its price target raised by Guggenheim from $440.00 to $490.00. They now have a “buy” rating on the stock.
• 9/21/2026 – Waters had its price target raised by The Goldman Sachs Group from $465.00 to $515.00. They now have a “buy” rating on the stock.
• 9/9/2026 – Waters was upgraded by UBS Group from “neutral” to “buy”. They now have a $490.00 price target on the stock, up from $375.00.
• 9/6/2026 – Waters was downgraded by Wall Street Zen from “buy” to “hold”.
• 9/1/2026 – Waters had its price target raised by HSBC from $450.00 to $455.00. They now have a “buy” rating on the stock.
• 8/29/2026 – Waters was upgraded by Wall Street Zen from “hold” to “buy”.

Insider Activity

In other news, Director Christopher Kuebler sold 3,626 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the transaction, the director owned 17,808 shares in the company, valued at $7,086,515.52. This trade represents a 16.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.31% of the company’s stock.

Waters Corporation (NYSE:WAT) develops and manufactures analytical technologies used to measure, identify and characterize chemical and biological substances. Its customers include pharmaceutical and biotechnology companies, industrial manufacturers, academic and government laboratories, and organizations involved in food, environmental and clinical testing.

The company’s product portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometers, chromatography columns and consumables, and laboratory software for data management and analysis.